Correction: A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)

Antzeko izenburuak

• A randomized, phase II study of gefitinib alone versus nimotuzumab plus gefitinib after platinum-based chemotherapy in advanced non-small cell lung cancer (KCSG LU12-01)
  nork: Kim, Hye Ryun, et al.
  Argitaratua: (2016)
• Nimotuzumab plus platinum-based chemotherapy platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
  nork: Yunshu Zhu, et al.
  Argitaratua: (2020-09-01)
• Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)
  nork: Sun, Jong-Mu, et al.
  Argitaratua: (2018)
• Nimotuzumab plus platinum-based chemotherapy versus platinum-based chemotherapy alone in patients with recurrent or metastatic nasopharyngeal carcinoma
  nork: Zhu, Yunshu, et al.
  Argitaratua: (2020)
• Phase II study of durvalumab and tremelimumab in pulmonary sarcomatoid carcinoma: KCSG‐LU16‐07
  nork: Kim, Miso, et al.
  Argitaratua: (2020)